Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization
Catheterization and Cardiovascular Interventions · 2023
DOI: 10.1002/ccd.30605 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Elodi Bacci und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Toscana, Italy. Hauptthemen laut MEDLINE: Coronary Occlusion, Fluoroscopy, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Chronic total occlusion (CTO) revascularization is a major source of radiation for both patients and physicians. Therefore, efforts to minimize radiation during CTO percutaneous coronary intervention (PCI) are highly encouraged.
Aims
To evaluate the impact of an Ultra Low fluoroscopic Dose Protocol (ULDP), based on 3.75 frames per second for the fluoroscopy and 7.5 frames per second for the cine acquisition, during CTO PCI.
Methods
One hundred fifty consecutive patients who underwent CTO PCI were retrospectively enrolled. Eighty‐five underwent standard dose protocol (SDP) and 65 ULDP. Radiation exposure and acute clinical outcomes were compared between groups. Results were stratified according to lesion complexity.
Results
Patients undergoing ULDP, as compared to those undergoing SDP, showed a significant reduction of kerma area product, both for simple lesions (6861.0 vs. 13236.0 mGy × cm 2 ; p = 0.014) and complex lesions (CL) (8865.0 vs. 16618.0 mGy × cm 2 ; p < 0.001). Similarly, Air Kerma (AK) was lower when ULDP was used (1222.5 vs. 2015.0 cGy in SL, p = 0.134; 1499.0 vs. 2794.0 cGy in CL, p < 0.001). No significant differences were reported regarding procedural success and in‐hospital major adverse cardiovascular events between groups. Notably, there was not any crossover from ULDO to SDP due to poor quality images. Interestingly, fluoroscopy time, procedural time and contrast volume was significantly lower in patients undergoing ULDP only for CLs.
Conclusions
ULDP significantly reduces radiation exposure in the setting of high complexity procedures such as CTO PCI. This reduction seemed to be greater with increased procedural complexity and did not impact acute success or adverse clinical events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Toscana, Italy.
- Humanitas Research Hospital IRCCS, Milan, Rozzano, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.
- Županijska bolnica Čakovec, Čakovec, Croatia.
ORCID-Profile: Mauro Chiarito, Jorge Sanz-Sanchez, Laura Novelli, Mihajlo Kovacic, Francesco Contorni
Zitieren
APA
Bacci, E., Chiarito, M., Sanz-Sanchez, J., Leone, P. P., Gohar, A., Novelli, L., Kovacic, M., Regazzoli, D., Reimers, B., Contorni, F., Ghionzoli, N., Cameli, M., & Gasparini, G. L. (2023). Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30605
Vancouver
Bacci E, Chiarito M, Sanz-Sanchez J, Leone PP, Gohar A, Novelli L, et al. Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30605
BibTeX
@article{Bacci2023,
author = {Bacci, Elodi and Chiarito, Mauro and Sanz-Sanchez, Jorge and Leone, Pier Pasquale and Gohar, Aisha and Novelli, Laura and Kovacic, Mihajlo and Regazzoli, Damiano and Reimers, Bernhard and Contorni, Francesco and Ghionzoli, Nicolò and Cameli, Matteo and Gasparini, Gabriele L},
title = {Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization},
journal = {Catheterization and Cardiovascular Interventions},
year = {2023},
doi = {10.1002/ccd.30605}
}
EUVIMED